Latest Topiramate Stories

2012-09-05 23:03:14

The Food and Drug Administration recently approved a new weight loss drug called Qsymia, its first weight loss drug approval in 13 years. Qsymia's own clinical studies show this weight loss pill only sheds a mere 10% of body weight per year or for a 200 pound person, a shy 20 pounds in one year. Diet Doc hCG Diet in-house study shows patients lose an average of 30 pounds per month. Dallas, TX (PRWEB) September 04, 2012 Diet Doc hCG Diet in-house study shows that patients lose an average of...

2012-08-10 23:00:13

On July 17th, 2012, the US FDA approved the new diet pill Qsymia by Vivus Inc. Qsymia is a combination of two FDA-approved drugs, phentermine and topiramate, in an extended-release formulation. Phentermine was one-half of the popular Wyeth obesity drug Fen Phen which was withdrawn from the market in 1997; it was linked with heart valve damage and primary pulmonary hypertension (PPH). Now, AttorneyOne.com, a recognized authority on law, can provide helpful, proven advice and simple solutions...

Qsymia: Third Weight-Loss Drug Approved BY FDA In Thirteen Years
2012-07-18 13:04:53

Lawrence LeBlond for redOrbit.com - Your Universe Online The second new weight-management drug in 13 years has been approved by US regulators for use in people who are obese or overweight and have certain medical conditions. The drug, Qsymia, developed by pharmaceutical company Vivus, received Food and Drug Administration (FDA) approval just a month after another anti-obesity drug, called Belviq, was given a thumbs up. Qsymia has been approved for use in obese adults with a body mass...

2012-06-25 23:25:24

An experimental drug helped significantly more overweight patients with diabetes shed pounds, compared with placebo, a new study finds. The results will be presented Saturday at The Endocrine Society's 94th Annual Meeting in Houston. "This new medication is promising because of the amount of weight loss it produces, the resultant improvement in important risk factors for diabetes, and, particularly in the lower dose studied, in its tolerability," said study lead author Donna H. Ryan, M.D.,...

2012-04-12 23:01:34

The Consumer Justice Foundation, a for-profit corporation that is staffed by a team of professional consumer advocates whose mission is to provide consumers with information regarding the potential dangers of certain prescription medications via free online informational resources, hereby alerts the public of an FDA announcement that its decision regarding whether or not to approve the topiramate-containing obesity medication Qnexa will not be made on April 17. Instead, the agency will make...

Word of the Day
  • Boughs or branches.
  • Warbling of birds in trees.